Photodynamic Therapy With Verteporfin for Juxtafoveal Choroidal Neovascularization in Pathologic Myopia: A Long-term Follow-up Study

American Journal of Ophthalmology

Volumn 143, Issue 3, 2007, Pages

  Pece, Alfredo ^a   Vadalà, Maria ^b   Isola, Vincenzo ^a   Matranga, Domenica ^b  

^a Melegnano Hospital   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MYOPIA; PRIORITY JOURNAL; REFRACTION ERROR; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY;

EID: 33847232947     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.11.037     Document Type: Article

References (20)

1. Avila M.P., Weiter J.J., Jalkh A.E., et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91 (1984) 1573-1581
2. Secretan M., Kuhn D., Soubrane G., and Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia. Natural history and laser treatment. Eur J Ophthalmol 7 (1997) 307-316
3. Yoshida T., Ohno-Matsui K., Ohtake Y., et al. Long-term visual prognosis of choroidal neovascularization in high myopia. A comparison between age groups. Ophthalmology 109 (2002) 712-719
4. Pece A., Brancato R., Avanza P., Camesasca F., et al. Laser photocoagulation of choroidal neovascularization in pathologic myopia: long-term results. Int Ophthalmol 18 (1995) 339-344
5. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 1. Ophthalmology 110 (2003) 667-673
6. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularization. Eye 15 (2001) 407-412
7. Montero J.A., and Ruiz-Moreno J.M. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87 (2003) 173-176
8. Pece A., Isola V., Vadalà M., and Matranga D. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: A long-term study. Retina 26 (2006) 746-751
9. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 3. Ophthalmology 110 (2003) 667-673
10. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: 1-year results of 2 randomized clinical trials-TAP Report No. 1. [published erratum appears in Arch Ophthalmol 2000;118:488]. Arch Ophthalmol 117 (1999) 1329-1345
11. Ferris III F.L., Kassoff A., Bresnick G.H., and Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 94 (1982) 91-96
12. Jalkh A.E., Weiter J.J., Trempe C.L., et al. Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg 18 (1987) 721-725
13. Ruiz-Moreno J.M., and Montero J.A. Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes. Eur J Ophthalmol 12 (2002) 117-122
14. Brancato R., Pece A., Avanza P., and Radrizzani E. Photocoagulation scar expansion after laser therapy of choroidal neovascularization in pathologic myopia. Retina 10 (1990) 239-243
15. Ergun E., Heinzl H., and Stur M. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138 (2004) 434-438
16. Axer-Siegel R., Ehrlich R., Weinberger D., et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 138 (2004) 602-607
17. Arroyo J.G., Michaud Norman M.S., and Jackobiec F.A. Choroidal neovascular membranes treated with photodynamic therapy. Arch Ophthalmol 121 (2003) 898-903
18. Cohen S.Y., Bulik A., Dubois L., and Quentel G. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes. Arch Ophthalmol 136 (2003) 371-374
19. Lam D.S.C., Liu D.T.L., Fan D.S.P., et al. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year result of a prospective series. Eye 19 (2005) 834-840
20. Blair M.P., Apte R.S., Miskala P.H., et al. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina 24 (2004) 501-506